Journal Club
1. Spectrum Of Pulmonary Fungal Pathogens And Antifungal Drug Susceptibility Among TB Relapse And Retreatment Samples At Selected Health Facilities In Kenya - PhD Research Update
0
IAVI-W001 Study Launched at the KAVI-Institute of Clinical Research
On 24th September 2019, the first volunteer was enrolled in the IAVI-W001 study at the KAVI-Institute of Clinical Research (KAVI-ICR) of the University of Nairobi. The occasion marks the beginning of the 12th HIV vaccine clinical trial to be conducted at KAVI-ICR since 2001. This is a first-in-human study that uses a Native-trimer HIV envelope design that will hopefully stimulate broadly neutralizing antibodies against HIV.
0
Strengthening Research Partnerships: Visit by Excella Biotechnologies Limited to KAVI-Institute of Clinical Research
The KAVI-Institute of Clinical Research (KAVI-ICR) was honoured to host Linda Muringo, Sales and Applications Director, and Ruth Kariuki, Applications Specialist and Sales, from Excella Biotechnologies Limited on a recent courtesy visit. The meeting brought together researchers and industry representatives to explore opportunities for stronger collaborations in advancing scientific research.